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• Cancer            a multifactorial disease , involving both environmental and 
genetic factors . 
• Flavonoids           one of the subclasses and most abundant form of polyphenol 
compounds , considered as secondary metabolites in plants , fruits and vegetable 
. 
• Structure             15 carbon skeleton and two benzene rings which are linked by 
a heterocyclic ring containing oxygen (1). 
• They have biological properties such as antioxidant activities , anti-inflammatory








example of flavonoids 
and their chemical 
structures
Sub classes and absorption 
• Based on molecular and chemical structures , hydroxylation and glycosylation 
of rings(1) , degree of oxidation and unsaturation of the linking chain(2) , 
sugars, oxygen and methyl groups attached to these structures , flavonoids 







• Flavonoles are the most abundant and common form 
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Sub classes and absorption 
• Biosynthesis         two different shikimic acid pathway and the acetate pathway(2) . 
• Dietary flavonoids that enter via oral cavity are mostly in glucoside forms and very 
soon they would be hydrolyses by different enzymes . 
• Metabolization pathway            mostly metabolize in intestine , then they are 
transmitted into liver , there they undergo further metabolization , then transported 
to target cells . 
• Flavonoids that reach the colon will degraded by colonic microbiota and reabsorb .     
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Beneffical effects of flavonoids and anti cancer 
properties 
• Anti-oxidant activity 
• Anti-inflammatory activity 
• Effects on immune system 
• Effects on cell signaling pathway 
• Effects on multidrug resistance 
• Inhibition on angiogenesis 
• Effects on cell apoptosis 
• Effects on epigenetic mechanisms 
• Effects on genome stability and cell cycle 
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Anti-oxidant activity 
• free radicals have unpaired electrons , make them reactive and harmful for lipids , 
proteins and DNA . 
• They peroxidases  cellular membrane‘s lipids and cause oxidative  damage . 
• Oxidative stress           unbalance production of oxygen radicals and detoxification
capacity of an organism(3) . 
• Flavonoids inhibit the production of free radicals ,  have scavenging activity for ROS , 
RNS and other reactive species . 
• Neutralize radicals from outside and inside of their catalytic domain ,  inactivation of 
reactive radicals . 
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Anti-oxidant activity 
• anti-oxidant properties may be related to chemical structure:
• Their hydroxyl groups that bond with aromatic rings(4) 
• Their structural hydrogens , give the potential to act as hydrogen donating 
molecules(1)  
• bond with proteins , repel radical formation , regulate enzymatic activities . Protect  
proteins from damage . 
• Covalant interaction leads to releasing of electrons by auto-oxidation , so fight with 
free radical formation and enzymatic oxidation 
• Metal chelation of enzymes 
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Anti-oxidant activity 
• ROS is an important and detrimental problems in tumorigenesis(1) : 
 Modifying the expression of NADPH-oxidase and superoxide that are highly 
express in tumors and suppress in tumor reduction . 
 Damages and changes DNA molecules into mutagenic forms 
 Act as a messenger in cell proliferation , anti-apoptotic and activation of 







• anti-inflammatory effects are due to ability to inhibit some regulatory enzymes and 
transcription factors . 
• it‘s stated that anti-inflammation effects of flavonoids depends on the DE conjugation 
of its glycoside to a glycoside(5) . 
• Different flavonoids could inhibit different protein kinases , such as : phosphoinositol 
kinas , protein kinase C , phosphatidyl inositol kinase , tyrosine kinase or cyclin-
dependent kinase C . 
• They also could inhibit phosphodiesterase(PDE) , enzyme that hydrolyses cAMP and 
c-GMP to keep them in normal levels. 
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Anti-inflammatory activity 
• Prenylated flavonoids extracted from Morus alba have potential to inhibit PDE4(6)  .  
• Flavonoids can reduce NF-Қb activity and attenuate its DNA-binding capacity(7) .
• Fiestin suppress IқB degradation , attenuate it‘s phosphorylation , in A549 cell lines 
, pretreatment with fiestin maintained the localization of  NF-Қb  in cytoplasm(8) .
• AP1 ,an pro-inflammatory transcription factor that is regulate by MAPK , ERK , C-
jun (7). 
• Flavonoids could inhibit phosphorylation of these kinases , reduces the activation of 
AP1 and decrease the transcription of their target genes . 
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Anti-inflammatory activity 
• Flavonoids also attenuate inflammation by impact on arachidonic acid metabolism 
and biosynthesis of mediators like : PLA2 , COX and LOX . 
• During inflammation , PLA2 metabolize membrane  phospholipids into arachidonic 
acid , cyclooxygenase  and lipoxygenase metabolized them into prostaglandins, 
thromboxane, leukotrienes . 
• For the inhibition of COX-1 prenylation of C-6 flavanones skeleton is important(9). 
• Phosphora flavanone inhibit the synthesis of PGE2 in RAW264.7 cells by inhibition 





• probable anti-inflammatory structures of Geranylated Flavonoids : 
 flavanones with a genaryl side chain modified by oxidation , formation of 
five-membered furan ring . 
 An unmodified side chain is crucial 
 The length of the chain also plays an important role . 
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Effects on immune cells 
• Flavonoids enhance natural killer cells activity via different mechanism(10):
 Quercetin mediate Nk-cells stimulatory activity through cellular signaling , inhibit 
protein kinase C , PIзK and heat-shock protein 70 in target cells . 
 flavonoids enter to NK-cells via unknown mechanism , alter granzyme-B expression 
, inhibit ca²+ channels , NA + / K+ ATPase and tyrosine kinase activity           
enhanced NK-cells activity .
 flavonoids modulate and/or increase target cells succeptibility to NK-cells by 
triggering the expression of NKG2D ligands , enhance the cytolytic activity of NK-
cells . 
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Effects on immune cells 
 In high doses flavonoids decrease NK-cells activity . 
• Chrystin , increase the regulation of macrophage2 genes (anti-inflammation ) and 
down regulation of macrophage 1 genes (pro-inflammatory ) (11) . 
• Quercetin activates extracellular iron export genes in dendritic cells , decrease 
intracellular iron reserves , dendritic cell‘s inflammatory activities would 
attenuate(12) . 
• Inhibition of monocyte adhesion functions , decrease the activation and proliferation 
responses on certain immune cells involving in chronic inflammations(1) .
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Effects on multi drug resistance 
• multi drug resistance (MDR)              over expression and/or over activation of 
membrane pumps that dislodge anti-cancer drugs . 
• Other causes of MDR              drug inactivation , detoxification mechanisms based on 
glutathione transferase activity , modification of drug targets , DNA damage repair , 
inhibition od cell death and … (13)
• p.glycoprotein (p.gp)  pumps that are belong to ABC transporter family (ATP-binding 
cassete ) are responsible for many MDR . 
• Activation of wnt/β-cathenin signaling molecules leads to over expression of p.gp . 
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Effects on multi drug resistance 
• Flavonoids inhibit  GSK3β(wnt) by interaction with ASP133 and VAL135 of ATP 
binding site of the protein , prevent translocation of β-cathenin to nucleus by 
phosphorylation degradation              down regulation of p.gp (14) .
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Effects on multi drug resistance 
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Effects on multi drug resistance 
protein Nrf2 and its 
downstream gene HO-1 
and NQO1 was assessed 
by Western blot inMCF-
7 and
MCF-7/TAM cells
Effects of EGCG on 
Nrf2 protein expression 
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Effects on cell signaling pathway 
• Flavonoids target downstream of cell signaling pathways , modulate function of cancer 
genes and transcription factors . 
• They target MEK signaling pathway by noncompetitive inhibition of ATP                         
block the signal transformation         blocking of EGF(15). 
• Isoflavone Daidzein suppressing ERK pathway by inhibition of  ERK  
phosphorylation and translocation from cytoplasm to nucleus (16). 
• Myricetin with ATP competitive property , binds to ATP binding site of AKT 
protein(17) .      
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Effects on cell signaling pathway 
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Inhibition of angiogenesis 
• Flavonoids interrupt angiogenesis by(15) : 
 Inhibition of oxygen supply 
 Diffusion of essential nutrient for angiogenesis 
 Inhibition of protein kinase 
 Interfere with gathering of  growth factors, transcription factors , receptors and other 
essential proteins(18) .
• Luteolin and quercetin          blocking the phosphorylation of JNK and JUK (not 
altering total protein ) in JNK signaling pathway , suppression of angiogenesis (19).   
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Inhibition of angiogenesis 
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Inhibition of angiogenesis 
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Effects of TF-SB on cell 
migration of HUVEC with 
different concentration 
Inhibition of angiogenesis 
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Effects of TF-BS on 
angiogenesis of CAM in 
different concentration 
Inhibition of angiogenesis 
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Hispidulin (HPDL) inhibits 





Effects on apoptosis 
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Effects on apoptosis 
35
Fisetin inhibited heat-
induced HSP70, HSP27 and 
BAG3 expression in HCT-
116 cancer cells
ChIP analysis of
HSF1 binding to the hsp70 
promoter.
Effects on apoptosis 
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Effects on apoptosis 
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Induction of apoptosis by 
kaempferol
Kaempferol suppressed ERα, 
Bcl-2 and survivin, and 
induced p53 and cleaved 
PARP expression.
Effects on epigenetic mechanisms 
• Flavonoids (quercetin ) can inhibit DNMT1 , suppress HAT activity , reduce 
global expression of HDAC1(20) . 
• In-silico analyses suggest structural similarities explain the abilities to 
interact with DNMT . 
• Ability to inhibit DNMT             directly binding and inhibiting the enzyme      
indirectly by reducing its expression
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Effects on epigenetic mechanisms 
• Quercetin : 
 inhibit HDAC .
 In human leukemia HL60 cells , increases the expression of fas ligand via 
increasing the acetylation of histone H3 . 
 Resistance of PC3 and DU145 prostate cancer cell lines to androgen-
derivation therapy is due to hyper-methylation of receptor genes . Quercetin
and curcumin hypomethylate mrna expression and induce apoptosis . 
• In PC3 and DU145 cell lines genistein and daidzein reduce methylation of 
BRCA1 , but not BRCA2 .   
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Effects on epigenetic mechanisms 
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Effects on epigenetic mechanisms 
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Effects of 3,6-DHF (20 mmol/L) treatment for 24 hours on the levels of miR-34a and 
miR-21 in breast cancer cells
Effects on epigenetic mechanisms 
effect of 3,6-DHF treatment for 24 
hours on the DNMT activity
effects of 3,6-DHF
treatment for 24 hours on the 
histone modifications of H3K9-
14ac, H3K27me3, and H3K27ac 
on miR-21 promoter
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Effects on epigenetic mechanisms
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Effects on epigenetic mechanisms
API increases the level of the 
nuclear translocation of the
Nrf2 protein
Apigenin Epigenetically Activates 
Nrf2 Gene
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Effects on genome stability and cell cycle 
• genome instability may causes by :
chemotherapy with alkylating agents 




 DNA damage response complex cascades , protect cells from 
carcinogenic stresses , regulates cell proliferation , cell cycle and apoptosis .
o Often active in early stages of cancer  
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Effects on genome stability and cell cycle 
mmunofluorescence determination of 
formation of cyclobutane pyrimidine 
dimmers (CPDs)
Expression of mRNA of G3PDH, XPA, 
DDB, and XPC in different sets of 











avone (luteolin) and 




immunoblot detection of 
caspase-3, -8 and -9, and B-cell 
lymphoma 2
(Bcl-2). NCI- H460 cells were 
mock-treated (control) or were 
treated with 20 μM luteolin only, 2 
Gy IR only, or the combination of 20 
μM luteolin and 2 Gy IR .
Roles of flavonoids in chemotherapy 
• Co-administration of apigenin increased the bio-availability of raloxafene in rats 
by competitively inhibiting its phase ‖ conjugation (21). 
• A case report in 2015 have demonstrated that Quercetin could improve anti-
neoplastic and anti-fatigue effects of Cyclophosphamide (22). 
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Roles of flavonoids in chemotherapy 
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Roles of flavonoids in chemotherapy 
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cells were treated with paclitaxel (10mM) alone or in combination with naringenin
Flavonoids and some 
diseases 
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Flavonoids and food allergy 
• In allergy reaction , TH2 and IgE and subsequent cytokines and chemolines are 
important (1).
• Food allergy is triggered by allergen permeation into intestinal epithelium via Para-
cellular diffusion .
• Treatments for food allergy         anti-histamine drugs which have side effects 
inhibition of immune response  
suppress allergen penetration by tight junctions 
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Flavonoids and food allergy 
• T-reg cell express transcription factors box protein p3 (FOxP3) , maintain immune 
tolerance and alleviate food allergy .
• Flavonoids inhibit the release of chemical mediators such as histamine , cyteinyl-
leukotiens and hexosaminidase .
• Quercetine and lueolin inhibit the synthesis of cytokines associated with the late-
phase of allergic reaction(23) . 
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Flavonoids and food allergy
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1, and JAM-1 
were 
evaluated as 
targets for the 
modulation of 
TJ
Flavonoids and food allergy 
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Flavonoids and food allergy 
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Relative gene expression of several molecules in small intestineWhite bars
represent H-RF group, black bars represent FA-RF group, white-striped bars represent FA-CC group
and grey bars represent FA-NFC group
Flavonoids and asthma 
• Asthma is a chronic respiratory disease with airway inflammation , obstruction and  
bronchial hyper responsiveness . 
• Several immune responses are involved in pathogenesis . 
• In-vitro analyses shows flavonoids beneficial features in asthma by influence on 
inflammatory mediators . 
• Vegetable and fruits rich in flavonoids was found to reduce the rick of asthma and 
wheeze . 
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skin hyperplasia in 
mice.
Flavonoids and asthma 
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Analysis of the effects of the indicated
concentrations of A18 on the extent of binding of IL-17RA–Fc to IL-17A (E), IL-17RB–Fc to IL-
17E (F), and IL-17RE–Fc to IL-17C (G).
flavonoids , Obesity and diabetes 
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flavonoids , Obesity and diabetes 
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flavonoids , Obesity and diabetes 
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flavonoids , Obesity and diabetes 
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GLUT-4 expression level Fasting blood glucose level
Flavonoids and cardio-vascular diseases 
• Blood pressure improvements in endothelial functions or directly affecting 
blood pressure  inhibiting angiotensin-converting enzyme . 
• Endothelial function by regulating vasodilators , nitric oxide (NO) , 
predisposing the vasculature to vasoconstriction(24) . 
• Total and cerebral blood flow           increasing the level of NO (24)
• platelet formation            via inhibition of ROS , modifying cytoskeleton proteins , 




Flavonoids and cardio-vascular diseases 
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Flavonoids and cardio-vascular diseases 
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The expression of p-p38 
MAPK following I/R and 
the effects of luteolin on 




quantitative analysis of the 
protein levels of SERCA2a 
by western blotting.
Hormetic effects of flavonoids 
• Hormesis is a dose-time response phenomenon characterized by a low-dose 
stimulatory response and a high-dose inhibition(26) . 
• In initial phases or low level of stressor exposure , biological systems adopt to the 
stress . increasing in dose or time of exposure , leads to toxicity cause biological 
responses could no longer adopt or compensate(27) .
• Flavonoids and polyphenols have hermetic effects , toxic in high enough doses(27) .
• Contaminant administration of them           synergically leads to toxic effects . 
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Hormetic effects of flavonoids 
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Hormetic effects of flavonoids 
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Effects of isoflavonoids on DNA synthesis in MCF-7 cells
Clinical trials of flavonoid 
and cancer  
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77
Clinical trials of flavonoid and cancer  
78
Reductions in the absolute lymphocyte 
count (ALC) and lymphadenopathy are 
shown. (Top) A waterfall
plot of best ALC declines during treatment 
is shown. (Bottom) , A waterfall plot of the 
best reduction in the sum of the
products of all lymph node areas is shown.
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